Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ProGo
- Development stage
- Unknown
- Lead developer
- Hofseth BioCare
- Modality
- Peptides
- Administration
- Oral
01
Overview
ProGo is a bioprocessed marine protein hydrolysate derived from Atlantic salmon (*Salmo salar*), developed by Hofseth BioCare. It is composed of highly bioavailable bioactive peptides and amino acids, produced through a proprietary enzymatic hydrolysis process that preserves the nutritional integrity of the source material. ProGo is primarily positioned as a nutraceutical and functional food ingredient, with clinical evidence supporting its use in weight management (reduction of BMI) and the treatment of iron deficiency anemia. Beyond metabolic and nutritional health, it is being investigated in preclinical and early-stage clinical research for its potential anti-inflammatory and regenerative effects in conditions such as necrotizing enterocolitis (NEC), inflammatory bowel disease (IBD), sarcopenia, and rheumatoid arthritis.
- Brand names
- ProGo
- Other names
- Salmon Protein HydrolysateSPH
02
Targets
HMOX1 (Heme oxygenase 1)GLP1R (GLP-1R)GIPR (Gastric inhibitory polypeptide receptor)DPP-4 (Dipeptidyl Peptidase-IV)FTH1 (Ferritin heavy chain)GDF8 (Myostatin)
Beyond the preview
Go deeper on ProGo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProGo.